Antonella Catalano
Biologin
Hat mitgewirkt an:
-
Mouse models and targeted therapies for RAS-driven tumours
-
Mouse genetic background influences whether Hras(G12V) expression plus Cdkn2a knockdown causes angiosarcoma or undifferentiated pleomorphic sarcoma
-
Oncogenic HrasG12V expression plus knockdown of Cdkn2a using ecotropic lentiviral vectors induces high-grade endometrial stromal sarcoma
-
Sensitivity and resistance of oncogenic RAS-driven tumors to dual MEK and ERK inhibition